| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |